« Back to whitepapers archive
Whitepapers
China: Opportunities for biotech firms
By: Rob Johnson and Li Zeng
Mar
2011
China is serious about medicine. Universal access to basic healthcare, an improving IP environment, Chinese companies desire for innovation and substantial funding opportunities are opening up possibilities for Western companies of all sizes.
Despite this, biotech’s business development priorities are US, EU and Japan. Now, it’s time to engage with China….
Download the full whitepaper PDF below: